Repository logo
  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Universidad Panamericana
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • Researchers
  • Statistics
  • Feedback
  • English
  • Deutsch
  • Español
  • Français
  1. Home
  2. CRIS
  3. Publications
  4. Linfoma anaplásico de células grandes : estudio clínico-patológico e inmunohistoquímica de 20 casos clasificados de acuerdo a la revisión de la Organización Mundial de la Salud de neoplasias linfoides de 2016
 
  • Details
Options

Linfoma anaplásico de células grandes : estudio clínico-patológico e inmunohistoquímica de 20 casos clasificados de acuerdo a la revisión de la Organización Mundial de la Salud de neoplasias linfoides de 2016

Journal
Gaceta Mexicana de Oncología
ISSN
2565-005X
Date Issued
2022
Author(s)
Sevilla Lizcano, Diana Brisa
Facultad de Ciencias de la Salud - CampCM  
Ortíz Hidalgo, Carlos Federico  
Facultad de Ciencias de la Salud - CampCM  
Type
Resource Types::text::journal::journal article
DOI
10.24875/j.gamo.M18000114
URL
https://scripta.up.edu.mx/handle/20.500.12552/2258
Abstract
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma composed of CD30-positive neoplastic cells. The 2016 revision of the WHO classification of lymphoid neoplasms includes anaplastic lymphoma kinase (ALK) positive, ALK negative and breast implant associated ALCL. ALCL have distinct clinical and prognostic features between positive and negative cases. ALK-1 positive cases mostly occur in the first three decades of life while patients with ALK-1 negative are older. ALCL exhibit a very broad range of cytology appearances that include common pattern, lymphohistiocytic pattern, small-cell pattern, Hodgkin-like pattern and composite pattern. By definition, ALCL show strong CD30 staining on the cell membrane and in the Golgi region and the majority are epithelial membrane antigen positive, express one or more T-cell or Natural Killer antigens and are constantly negative for Epstein-Barr virus. We present the clinicopathologic and immunohistochemical analysis of 20 cases of ALCL studied at a single institution, classified according to the 2016 revision of lymphoid neoplasms. Nine cases were ALK-1 positive, ten ALK-1 negative, and one case as a breast implant associated ALCL ALK-1 negative. © 2017 Sociedad Mexicana de Oncología.
Subjects

Anaplastic large cell...

Anaplastic lymphoma k...

CD30

Immunohistochemistry

Epithelial membrane a...

T lymphocyte antigen

Cancer classification...

Cancer localization

Cancer morphology


Copyright 2024 Universidad Panamericana
Términos y condiciones | Política de privacidad | Reglamento General

Built with DSpace-CRIS software - Extension maintained and optimized by - Hosting & support SCImago Lab

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback